SCHEMBL20821376

SCHEMBL20821376

CC(C)(CS)c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ ADORA1 P30542 5/20 0.39
▸ ADORA2A P29274 3/20 0.39
▸ POLB P06746 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ DPP4 P27487 2/20 0.39
▸ IDH2 P48735 1/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ NR1H2 P55055 1/20 0.36
▸ NR1H3 Q13133 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15447621 0.78 L3MBTL1 (0.58) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL23719337 0.77 L3MBTL1 (0.44) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL23680532 0.76 L3MBTL1 (0.50) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL19862827 0.75 L3MBTL1 (0.54) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL28203232 0.75 L3MBTL1 (0.54) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL19735249 0.75 L3MBTL1 (0.54) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL25878006 0.75 L3MBTL1 (0.54) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL17878916 0.74 L3MBTL1 (0.52) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL13053155 0.73 L3MBTL1 (0.56) L3MBTL1ADORA1ADORA2APOLBADORA3
SCHEMBL19723672 0.73 L3MBTL1 (0.52) L3MBTL1ADORA1ADORA2APOLBADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11021484-B2 Compound including nitrogen and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-01 — — US disclosed
US-20190084992-A1 COMPOUND INCLUDING NITROGEN AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190084992-A1 COMPOUND INCLUDING NITROGEN AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME OR10J3, L1CAM, NOS1 L3MBTL1 1107/4885ADORA1 140/4885ADORA2A 1588/4885
US-11021484-B2 Compound including nitrogen and organic electroluminescence device including the same OR10J3, L1CAM, NOS1 L3MBTL1 1107/4885ADORA1 140/4885ADORA2A 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback